Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review
Journal of Cutaneous Medicine and Surgery · 2025
DOI: 10.1177/12034754241287546 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2025. Verfasst von Nicholas J Hua und 4 weiteren Autor:innen. Beteiligte Einrichtung: Temerty School of Medicine, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Rosacea, Erythema, Dermatologic Agents, Facial Dermatoses. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rosacea is a chronic inflammatory skin condition that affects over 5% of individuals worldwide. Its clinical presentation is characterized by an array of features, including erythema, papules and pustules, phymatous changes, telangiectasia, and ocular manifestations. Specifically, the multifaceted manifestation of erythema varies widely in intensity and distribution. Factors contributing to pathogenesis include neurovascular dysregulation, increased levels of pro-inflammatory mediators, and aberrant vasodilation. Erythema management plays an important role in reducing the psychosocial burden associated with rosacea and improving overall quality of life. Cochrane CENTRAL, Medline, and Embase databases were searched from inception to September 2023 and included 33 clinical trials reporting on a total of 7411 rosacea patients (74.1% female) and 21 different topical or systemic treatments. The mean age was 48.8 years (range, 18-83 years), and the mean time to outcome assessment was 8.1 weeks (standard deviation, 4.1 weeks). Treatment efficacy was assessed by outcome measures including percent improvement from baseline on 4- and 5-point scales, clinician erythema assessment (CEA) success (improvement ≥1 point), and CEA and patient self-assessment success (improvement ≥1 point). Pooled effect sizes for each treatment were calculated as a weighted average based on the number of patients in each study. The most effective topical treatments for reducing erythema include sodium sulphacetamide and sulphur, praziquantel, metronidazole, and B244 spray ( Nitrosomonas eutropha ). The most effective systemic treatment was paroxetine. Our findings highlight the varying efficacy of treatments in addressing the erythema in rosacea, recognizing the nuances of clinical presentations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Temerty School of Medicine, University of Toronto, Toronto, ON, Canada.
- Dalla Lana School of Public Health & Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
- Division of Pediatric Dermatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Nicholas J Hua, Ryan S Q Geng
Zitieren
APA
Hua, N. J., Chen, J., Geng, R. S. Q., Sibbald, R. G., & Sibbald, C. (2025). Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754241287546
Vancouver
Hua NJ, Chen J, Geng RSQ, Sibbald RG, Sibbald C. Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 2025. doi:10.1177/12034754241287546
BibTeX
@article{Hua2025,
author = {Hua, Nicholas J and Chen, Jennifer and Geng, Ryan S Q and Sibbald, Ronald Gary and Sibbald, Cathryn},
title = {Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2025},
doi = {10.1177/12034754241287546}
}
EUVIMED